A new study delved into the effects of moderate consumption of alcohol on the biodiversity of the intestinal microbiome and it has some good news for red wine drinkers.
The Massachusetts-based company OpenBiome is willing to pay $13,000 a year for a steady stream of healthy fecal matter that is used to treat patients suffering from a debilitating intestinal bacteria called C. difficile.